Gardner Roy S, Chong Kwok S, O'Meara Eileen, Jardine Alan, Ford Ian, McDonagh Theresa A
Department of Cardiology, Royal Infirmary, Alexandra Parade, Glasgow, UK.
Eur Heart J. 2007 Dec;28(24):3027-33. doi: 10.1093/eurheartj/ehm480. Epub 2007 Oct 29.
This study evaluates the prognostic utility of renal dysfunction estimated by the recently validated modification of diet in renal disease (MDRD) equations and compares it with the currently most promising predictor of prognosis in patients with advanced heart failure.
We prospectively studied 182 consecutive patients with advanced chronic heart failure (CHF) referred for consideration of cardiac transplantation, with a median follow-up of 642 days. Glomerular filtration rate (GFR) was estimated using the MDRD equations and plasma taken for NT-proBNP analysis. The primary endpoint of all-cause mortality was reached in 40 patients (13.2% crude 1-year mortality), and the combined secondary endpoint of all-cause mortality or urgent CTx was reached in 44 patients. The mean GFR estimated by MDRD-1 was 58 mL/min/1.73 m(2). The median NT-proBNP concentration was 1505 (517-4014) pg/mL. Although GFR estimated by MDRD-1 was a univariate marker of all-cause mortality, the only predictor of either endpoint independent of other variables was an NT-proBNP concentration above the median.
NT-proBNP appears superior to GFR estimated by MDRD in patients with advanced CHF. Moreover, NT-proBNP was able to identify patients with a poor prognosis whose GFR was already low.
本研究评估通过最近验证的肾脏疾病饮食改良(MDRD)方程估算的肾功能不全的预后价值,并将其与目前晚期心力衰竭患者最有前景的预后预测指标进行比较。
我们前瞻性地研究了182例连续的晚期慢性心力衰竭(CHF)患者,这些患者因考虑心脏移植而被转诊,中位随访时间为642天。使用MDRD方程估算肾小球滤过率(GFR),并采集血浆进行NT-proBNP分析。40例患者(粗1年死亡率为13.2%)达到全因死亡的主要终点,44例患者达到全因死亡或紧急心脏移植的联合次要终点。MDRD-1估算的平均GFR为58 mL/min/1.73 m²。NT-proBNP浓度中位数为1505(517-4014)pg/mL。虽然MDRD-1估算的GFR是全因死亡的单变量指标,但独立于其他变量的任何一个终点的唯一预测指标是NT-proBNP浓度高于中位数。
在晚期CHF患者中,NT-proBNP似乎优于MDRD估算的GFR。此外,NT-proBNP能够识别GFR已经很低但预后不良的患者。